Premium
Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab
Author(s) -
Suh KY.,
Kindler H.L.,
Medenica M.,
Lacouture M.
Publication year - 2006
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2005.07010.x
Subject(s) - paronychia , cetuximab , medicine , dermatology , hematology , doxycycline , antibiotics , biology , colorectal cancer , cancer , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom